Medicare Enrolled
Dr. Bei Liu, MD, PHD
Hematology & Oncology · Saginaw, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Liu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Liu
Dr. Bei Liu is a hematology & oncology specialist in Saginaw, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Liu performed 13,225 Medicare services across 1,840 unique beneficiaries.
Between the years covered by Open Payments, Dr. Liu received a total of $12,422 from 68 pharmaceutical and/or device companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Liu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 20% volume in MI
$12,422 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,225
Medicare services
Top 20% in MI for hematology & oncology
1,840
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~696 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,700 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,592 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
745 | $8 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
584 | $88 | $199 |
| Anti-nausea injection (ondansetron/Zofran) | 566 | $0 | $2 |
| Anti-nausea injection (Aloxi/palonosetron) | 490 | $1 | $10 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
419 | $10 | $25 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
396 | $22 | $100 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
379 | $8 | $10 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
265 | $61 | $150 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
232 | $98 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
216 | $11 | $40 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
162 | $2 | $28 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
147 | $18 | $63 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
120 | $6 | $56 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
117 | $11 | $80 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
98 | $48 | $175 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
96 | $134 | $325 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
85 | $1 | $2 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
80 | $16 | $65 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
79 | $21 | $55 |
| New patient office visit, complex (60-74 min) | 76 | $145 | $290 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
59 | $1 | $5 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
58 | $1 | $10 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
53 | $43 | $160 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
49 | $6 | $10 |
| Injection, lorazepam, 2 mg | 48 | $1 | $2 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
44 | $9 | $50 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
43 | $1 | $20 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
28 | $19 | $48 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
28 | $13 | $25 |
| Iron level test | 28 | $6 | $15 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
28 | $9 | $18 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
28 | $16 | $50 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
23 | $28 | $95 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $134 | $240 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
19 | $66 | $150 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
13 | $18 | $35 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
12 | $15 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.3% high complexity
70.0% medium
23.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,422
Total received (2018-2024)
Avg $1,775/year across 7 years
Top 14% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
377
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,405 (51.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,579 (28.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,438 (19.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,159
2023
$1,597
2022
$368
2021
$155
2020
$988
2019
$1,435
2018
$5,721
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$437
Novartis Pharmaceuticals Corporation
$262
Genentech USA, Inc.
$248
Lilly USA, LLC
$136
Janssen Biotech, Inc.
$128
PFIZER INC.
$97
Eisai Inc.
$74
AstraZeneca Pharmaceuticals LP
$67
Celgene Corporation
$62
Regeneron Healthcare Solutions, Inc.
$57
ARRAY BIOPHARMA INC
$55
Merck Sharp & Dohme LLC
$55
Takeda Pharmaceuticals U.S.A., Inc.
$51
GlaxoSmithKline, LLC.
$46
BeiGene USA, Inc.
$45
EMD Serono, Inc.
$45
Gilead Sciences, Inc.
$44
Apellis Pharmaceuticals, Inc.
$40
JAZZ PHARMACEUTICALS INC.
$29
Genmab U.S., Inc.
$27
ADC Therapeutics America, Inc.
$23
Daiichi Sankyo Inc.
$22
Myriad Genetic Laboratories, Inc.
$22
Blueprint Medicines Corporation
$21
E.R. Squibb & Sons, L.L.C.
$20
Deciphera Pharmaceuticals Inc.
$17
Aveo Pharmaceuticals, Inc.
$16
ABBVIE INC.
$14
Top 3 companies account for 43.8% of 2024 payments
All-time payments by company (2018-2024) ›
Puma Biotechnology, Inc.
$3,441
Tosoh Bioscience, Inc.
$1,084
Genentech USA, Inc.
$772
Janssen Biotech, Inc.
$770
Novartis Pharmaceuticals Corporation
$649
PFIZER INC.
$523
Astellas Pharma US Inc
$503
Athenex Pharmaceutical Division, LLC
$350
Lilly USA, LLC
$331
AstraZeneca Pharmaceuticals LP
$228
Takeda Pharmaceuticals U.S.A., Inc.
$223
Celgene Corporation
$214
Novocure GmbH
$200
Amgen Inc.
$192
Alexion Pharmaceuticals, Inc.
$185
Gilead Sciences, Inc.
$168
Eisai Inc.
$157
GENZYME CORPORATION
$151
COMSORT, Inc
$150
E.R. Squibb & Sons, L.L.C.
$135
EISAI INC.
$110
EMD Serono, Inc.
$109
Merck Sharp & Dohme LLC
$107
JAZZ PHARMACEUTICALS INC.
$104
BeiGene USA, Inc.
$98
Apellis Pharmaceuticals, Inc.
$97
Regeneron Healthcare Solutions, Inc.
$86
AVEO Pharmaceuticals, Inc.
$78
Incyte Corporation
$74
ARRAY BIOPHARMA INC
$74
Merck Sharp & Dohme Corporation
$73
Bayer HealthCare Pharmaceuticals Inc.
$65
Blueprint Medicines Corporation
$51
Kite Pharma, Inc.
$48
AbbVie, Inc.
$48
TerSera Therapeutics LLC
$46
GlaxoSmithKline, LLC.
$46
Teva Pharmaceuticals USA, Inc.
$40
Ipsen Biopharmaceuticals, Inc
$39
Mirati Therapeutics, Inc.
$39
Taiho Oncology, Inc.
$38
Daiichi Sankyo Inc.
$33
TESARO, Inc.
$33
Exelixis Inc.
$32
Deciphera Pharmaceuticals Inc.
$31
Array BioPharma Inc.
$29
Genmab U.S., Inc.
$27
Seagen Inc.
$23
ADC Therapeutics America, Inc.
$23
Myriad Genetic Laboratories, Inc.
$22
PharmaEssentia USA Corporation
$22
Jazz Pharmaceuticals Inc.
$21
Sumitomo Pharma America, Inc.
$21
Seattle Genetics, Inc.
$19
Fortovia Therapeutics, Inc.
$18
Advanced Accelerator Applications
$17
Aveo Pharmaceuticals, Inc.
$16
Karyopharm Therapeutics Inc.
$14
ABBVIE INC.
$14
INSYS Therapeutics Inc
$13
Inari Medical, Inc.
$13
Janssen Pharmaceuticals, Inc
$13
Verity Pharmaceuticals Inc.
$13
Shire North American Group Inc
$12
Kyowa Kirin, Inc.
$12
AMAG Pharmaceuticals, Inc.
$12
Epizyme, Inc.,
$12
Helsinn Therapeutics (U.S.), Inc.
$11
Top 3 companies account for 42.6% of all-time payments
Associated products mentioned in payments ›
6 · ADCETRIS · AIA-PACK · AKYNZEO · ALIMTA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · B12 · BAVENCIO · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · Columvi · DARZALEX · ELIQUIS · ELITEK · ENJAYMO · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · INJECTAFER · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MYLOTARG · MYRISK · NINLARO · Nerlynx · Neulasta · Nubeqa · OPDIVO · OPDUALAG · ORGOVYX · POTELIGEO · PROMACTA · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · S · SANDOSTATIN LAR · SCEMBLIX · SOMATULINE DEPOT · SUTENT · SYNDROS · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · Tecentriq · Trelstar · Trodelvy · ULTOMIRIS · Ultomiris · VERZENIO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (52%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
9
Per 100K population
4.8
County median income
$58,347
Nearest hospital
HEALTHSOURCE SAGINAW
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Liu is a mixed practice specialist, with above-average Medicare volume (top 20% in MI), with low-engagement industry engagement in the top 14% of MI peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Liu experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Liu performed 5,700 anti-nausea injection (fosaprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Liu receive payments from pharmaceutical companies?
Yes. Dr. Liu received a total of $12,422 from 68 companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liu's costs compare to other hematology & oncology specialists in Saginaw?
Dr. Liu's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Saginaw
Browse hematology & oncology specialists in Saginaw ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Puma Biotechnology, Inc. Payments to Doctors
See all physicians who received payments from Puma Biotechnology, Inc.
By company
Tosoh Bioscience, Inc. Payments to Doctors
See all physicians who received payments from Tosoh Bioscience, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology